- JP-listed companies
- Kohjin Bio Co., Ltd.
- Balance sheet
Kohjin Bio Co., Ltd. (177A) Balance sheet
Market cap
¥5B
P/E ratio
45.5x
Kojin Bio manufactures bacterial culture media, antigen test kits, and cell culture products for research institutions, pharmaceutical companies, and medical facilities.
| 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Cash and cash equivalents | - | 1,734 | 1,463 | 1,727 | 3,149 | 2,486 |
| Inventories | - | 190 | 366 | 247 | 313 | 295 |
| Total current assets | - | 3,434 | 3,479 | 3,410 | 5,067 | 4,268 |
| Property, plant and equipment, net | - | 1,709 | 2,172 | 2,587 | 3,254 | 3,798 |
| Marketable securities, non-current | - | 390 | 410 | 482 | 581 | 661 |
| Total non-current assets | - | 2,161 | 2,656 | 3,179 | 4,000 | 4,636 |
| Total assets | - | 5,595 | 6,135 | 6,589 | 9,067 | 8,904 |
| Accounts payable | - | 218 | 146 | 163 | 134 | 117 |
| Short-term debt | - | 900 | 1,200 | 1,500 | 1,500 | 1,500 |
| Long-term debt, current | - | 210 | 865 | 150 | 150 | 150 |
| Total current liabilities | - | 2,198 | 3,022 | 2,398 | 2,487 | 2,369 |
| Total non-current liabilities | - | 1,180 | 95 | 849 | 798 | 590 |
| Total liabilities | - | 3,378 | 3,117 | 3,247 | 3,285 | 2,959 |
| Retained earnings | - | 1,435 | 2,223 | 2,529 | 3,265 | 3,393 |
| Stockholders' equity | 1,579 | 2,217 | 3,018 | 3,342 | 5,782 | 5,945 |